Factors associated with exacerbations among adults with asthma according to electronic health record data

Asthma Research and Practice

Research Open Access
Rebecca E. GreenblattEdward J. ZhaoSarah E. HenricksonAndrea J. ApterRebecca A. Hubbard and Blanca E. HimesEmail authorView ORCID ID profile

Abstract

Background

Asthma is a chronic inflammatory lung disease that affects 18.7 million U.S. adults. Electronic health records (EHRs) are a unique source of information that can be leveraged to understand factors associated with asthma in real-life populations. In this study, we identify demographic factors and comorbidities associated with asthma exacerbations among adults according to EHR-derived data and compare these findings to those of epidemiological studies.

Methods

We obtained University of Pennsylvania Hospital System EHR-derived data for asthma encounters occurring between 2011 and 2014. Regression analyses were performed to model asthma exacerbation frequency as explained by age, sex, race/ethnicity, health insurance type, smoking status, body mass index (BMI) and various comorbidities. We analyzed data from the National Health and Nutrition Examination Survey (NHANES) from 2001 to 2012 to compare findings with those from the EHR-derived data.

Results

Based on data from 9068 adult patients with asthma, 33.37% had at least one exacerbation over the four-year study period. In a proportional odds logistic regression predicting number of exacerbations during the study period (levels: 0, 1–2, 3–4, 5+ exacerbations), after controlling for age, race/ethnicity, sex, health insurance type, and smoking status, the highest odds ratios (ORs) of significantly associated factors were: chronic bronchitis (2.70), sinusitis (1.50), emphysema(1.39), fluid and electrolyte disorders (1.35), class 3 obesity (1.32), and diabetes(1.28). An analysis of NHANES data showed associations for class 3 obesityanemiaand chronic bronchitis with exacerbation frequency in an adjusted model controlling for age, race/ethnicity, sex, financial class and smoking status.

Conclusions

EHR-derived data is helpful to understand exacerbations in real-life asthma patients, facilitating design of detailed studies and interventions tailored for specific populations.

Download PDF

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @EAACI_HQ: A promising new diagnostic assay able to identify different phenotypes and degree of #CMA #foodallergy #Allergy_journal https…
4hreplyretweetfavorite
Interasma RT @AllergyEaaci: Delayed drug hypersensitivity to bortezomib: desensitization and tolerance to its analogue carfilzomib. Corresponding Aut…
4hreplyretweetfavorite
Interasma RT @worldallergy: WAO Tweeted Times https://t.co/1tA4uy3LDq - top stories by @EAACI_HQ
4hreplyretweetfavorite
4hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma